| Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations KR McSweeney, LK Gadanec, T Qaradakhi, BA Ali, A Zulli, ... Cancers 13 (7), 1572, 2021 | 263 | 2021 |
| Can SARS-CoV-2 virus use multiple receptors to enter host cells? LK Gadanec, KR McSweeney, T Qaradakhi, B Ali, A Zulli, ... International journal of molecular sciences 22 (3), 992, 2021 | 164 | 2021 |
| The anti-inflammatory effect of taurine on cardiovascular disease T Qaradakhi, LK Gadanec, KR McSweeney, JR Abraham, ... Nutrients 12 (9), 2847, 2020 | 130 | 2020 |
| Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles A Liskova, M Samec, L Koklesova, A Brockmueller, K Zhai, B Abdellatif, ... Epma Journal 12 (2), 155-176, 2021 | 110 | 2021 |
| The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases T Qaradakhi, LK Gadanec, KR McSweeney, A Tacey, V Apostolopoulos, ... Clinical and Experimental Pharmacology and Physiology 47 (5), 751-758, 2020 | 97 | 2020 |
| Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2 H Ridgway, GJ Moore, T Mavromoustakos, S Tsiodras, I Ligielli, ... Computational and structural biotechnology journal 20, 2091-2111, 2022 | 33 | 2022 |
| Understanding the driving forces that trigger mutations in SARS-CoV-2: mutational energetics and the role of arginine blockers in COVID-19 therapy H Ridgway, CT Chasapis, K Kelaidonis, I Ligielli, GJ Moore, LK Gadanec, ... Viruses 14 (5), 1029, 2022 | 32 | 2022 |
| Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: A proposed approach to SARS-CoV-2 treatment L Kate Gadanec, T Qaradakhi, K Renee McSweeney, B Ashiana Ali, ... Future Microbiology 16 (4), 205-209, 2021 | 30 | 2021 |
| The effect of recombinant undercarboxylated osteocalcin on endothelial dysfunction T Qaradakhi, LK Gadanec, AB Tacey, DL Hare, BF Buxton, ... Calcified tissue international 105, 546-556, 2019 | 25 | 2019 |
| Receptor interactions of angiotensin II and angiotensin receptor blockers—relevance to COVID-19 GJ Moore, JM Pires, K Kelaidonis, LK Gadanec, A Zulli, V Apostolopoulos, ... Biomolecules 11 (7), 979, 2021 | 22 | 2021 |
| Role of angiotensin II in cardiovascular diseases: Introducing bisartans as a novel therapy for coronavirus 2019 J Swiderski, LK Gadanec, V Apostolopoulos, GJ Moore, K Kelaidonis, ... Biomolecules 13 (5), 787, 2023 | 21 | 2023 |
| Could DIZE be the answer to COVID-19? T Qaradakhi, L Gadanec, J Matsoukas, V Apostolopoulos, A Zulli Maturitas 140, 83, 2020 | 14 | 2020 |
| Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels LK Gadanec, T Qaradakhi, KR McSweeney, JM Matsoukas, ... Biochemical Pharmacology 208, 115397, 2023 | 12 | 2023 |
| Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers 2021; 13: 1572 KR McSweeney, LK Gadanec, T Qaradakhi, BA Ali, A Zulli, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 10 | 2021 |
| Combination of taurine and black pepper extract as a treatment for cardiovascular and coronary artery diseases J Swiderski, S Sakkal, V Apostolopoulos, A Zulli, LK Gadanec Nutrients 15 (11), 2562, 2023 | 9 | 2023 |
| Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome coronavirus 2 JM Matsoukas, LK Gadanec, A Zulli, V Apostolopoulos, K Kelaidonis, ... Biomedicines 10 (7), 1731, 2022 | 8 | 2022 |
| Glycyrrhizic acid inhibits high-mobility group box-1 and homocysteine-induced vascular dysfunction LK Gadanec, U Andersson, V Apostolopoulos, A Zulli Nutrients 15 (14), 3186, 2023 | 5 | 2023 |
| Imipridone enhances vascular relaxation via FOXO1 pathway KR McSweeney, LK Gadanec, T Qaradakhi, TM Gammune, P Kubatka, ... Clinical and Experimental Pharmacology and Physiology 47 (11), 1816-1823, 2020 | 5 | 2020 |
| Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies H Ridgway, GJ Moore, LK Gadanec, A Zulli, V Apostolopoulos, ... Expert Opinion on Therapeutic Targets 28 (5), 437-459, 2024 | 4 | 2024 |
| Existence of quantum pharmacology in Sartans: evidence in isolated rabbit iliac arteries LK Gadanec, J Swiderski, V Apostolopoulos, K Kelaidonis, VP Vidali, ... International Journal of Molecular Sciences 24 (24), 17559, 2023 | 4 | 2023 |
